Interview with Jubilant’s President Chris Preti

Key Learning Objectives:

• Progress on previously announced $285 million expansion plan will double capacity for sterile injectables fill/finish at Jubilant HollisterStier’s Spokane, Wash. Facility
• Strengthen’s Jubilant HollisterStier’s position in addressing contract manufacturing needs of major producers throughout North America
• Jubilant HollisterStier is a leading contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids